Look out for Clinical Informatics research from HCMP at this year's Diabetes UK conference!
Friday 21 December 2012
Our diabetes research team in collaboration with colleagues at the Chelsea and Westminster, Leicester and Royal Surrey County hospitals have succeeded in getting two oral presentations and four posters into the Diabetes UK Annual Professional Conference. The conference which takes place in Manchester (13 – 15 March) is the premier healthcare conferences in the UK attracting over 3000 attendees and covers a wide range of scientific and clinical themes related to diabetes care. We will be presenting data on the clinical management of diabetes in primary care; the relationship of diabetes, kidney disease, and hypertension; early analysis of the Global Attitudes of Patient and Physicians (GAPP2™) survey, the quality of primary care follow-up for women who have developed diabetes during pregnancy as well as providing insights into the difficulties diagnosing diabetes in young patients.
Presentation (Friday 15 March 2013, commencing at 14:35)
People with diabetes and unmonitored renal function are at increased risk of an adverse outcome: cohort study.
This study highlights the importance of close monitoring of renal function in primary care. Whilst most people with diabetes have regular checks of their renal function, those people who don’t have increased mortality. We aim to challenge what was perhaps conventional wisdom; that people who are clinically well do not benefit from regular renal function testing. We also demonstrate that failure to monitor renal function is associated with wider clinical neglect in these patients.
Presentation (Friday 15 March 2013, commencing at 14.20)
The interrelationship between hypertension, chronic kidney disease and proteinuria in people with diabetes: cohort study.
We demonstrate that the effects of hypertension, renal impairment, and proteinuria all have an additive effect on mortality in people with diabetes. We therefore suggest that each of these disease components should be sought out and carefully managed. This is particularly important in the case of proteinuria and renal impairment which are often regarded as the same clinical entity.
Poster (Number: P199)
Difficulties in classifying Diabetes in a young obese patient
Case presentation of patient with probable insulinitis (and positive autoimmunity) at presentation who required insulin therapy. Currently normal glycaemic in “an autoimmune milieu” twenty months post presentation. This case illustrates the difficulty in classifying diabetes in young obese patients without a diabetes FH, presenting with marked hyperglycaemia without ketonuria. It remains to be seen whether beta cell failure will evolve in due course.
Poster (Number: P404)
Incidence, worry and discussion of self-treated hypoglycaemia amongst UK Type 2 diabetes patients and prescribers: results from the Global Attitudes of Patient and Physicians (GAPP2™) survey.
The GAPP2™ surveys were designed to increase understanding of self-treated hypoglycaemia in UK patients with Type 2 diabetes. Patients with Type 2 diabetes using insulin analogues, and healthcare professionals managing these patients from USA, Canada, Japan, UK, Germany and Denmark were recruited for the study. Data from 322 patients and 208 prescribers in the UK are presented. Self-treated hypoglycaemia is common among UK patients with Type 2 diabetes. Patients worry particularly about nocturnal hypoglycaemia and some try to mitigate this risk by letting their blood glucose rise
Poster (Number: P475)
Postnatal monitoring for diabetes following gestational diabetes in the UK.
Current guidelines recommend fasting glucose testing at 6 weeks after delivery for all women diagnosed with gestational diabetes. We show that postnatal follow-up in the UK is poor with around 80% of women remaining untested at six months after delivery. We aim to characterise the current state of postnatal follow-up and discuss ways in which this can be improved in primary care.
Poster (Number: P574)
UK Type 2 diabetes patients and prescriber experience of basal insulin dosing irregularities: results from the Global Attitudes of Patients and Physicians (GAPP2™) survey
The GAPP2 survey aimed to address gaps in understanding about real-world basal insulin-taking behaviour in Type 2 diabetes. The survey was performed in six countries: USA, Canada, Japan, UK, Germany and Denmark. Data from 322 patients and 208 prescribers in the UK are presented. Basal dosing irregularities are common among UK patients with Type 2 diabetes and their potential impact is not always recognised. Additionally, a substantial proportion of prescribers do not routinely discuss these challenges with their patients.
For additional details on the conference please see the Diabetes UK website: http://www.diabetes.org.uk/Diabetes-UK-Professional-Conference/.
Dr Andrew McGovern,
Dr Neil Munro,
Professor Simon Jones,
Professor Simon de Lusignan on behalf of the research team